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CASE REPORT
Isolated Late Metastasis of a Renal Cell Cancer
Treated by Radical Distal Pancreatectomy
J.P. BARRAS*, H. BAER*, A. STENZL and A. CZERNIAK*
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Switzerland
Department of urology, University of Bern, Inselspital, CH-3010 Bern, Switzerland
(Received 30 July 1995)
A 53-year-old man underwent right nephrectomy for a locally advanced renal cell carcinoma with
concomitant resection of a solitary metastasis in the right lung. Ten years later, he presented with
haematochezia caused by a tumour in the tail of pancreas, invading the transverse colon and the greater
curvature of the stomach. The tumour was radically resected, and histological examination revealed a
solitary metastasis of the previous renal cell carcinoma. This case illustrates a rare indication for
pancreatic resection because of pancreatic metastasis.
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INTRODUCTION
At the time of diagnosis approximately 23% of all
renal cell carcinomas are metastatic 1. Most patients
present with multiple metastases, solitary metastasis
being rare. The value of surgical treatment in such
cases, i.e. nephrectomy plus excision of one or more
metastases, in uncertain, but it is sometimes carried
out for lack of satisfactory alternatives. Solitary late
recurrence, defined as metastasis occurring 10 years or
more after diagnosis of the primary renal tumour is
also uncommon and has an unfavourable prognosis.
Pancreatic metastases are much less common than
pulmonary metastases but can be the presenting fea-
ture of a kidney neoplasm2.
CASE REPORT
A 53-year-old man presented in 1982 with a solitary
right pulmonary nodule on a routine chest X-ray and
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late metastasis pancreatic metastasis
a large right flank mass of renal origin on computer
tomography (CT). Detailed imaging revealed no
other tumours. A right nephrectomy and an inferior
right pulmonary lobectomy were performed. The his-
tology showed a well-differentiated clear cell carci-
noma penetrating into the perirenal fat (pT3) without
lymph node involvement. The 3 cm diameter pulmo-
nary nodule was a well demarcated metastasis. An-
nual checks revealed no evidence of recurrent disease.
In 1992 haematochezia developed, and colonoscopy
showed an infiltrating tumour of the left colonic
flexure. On abdominal CT (Fig. 1) a large tumour was
seen infiltrating the body and tail of pancreas, left
colonic flexure and greater curvature of the stomach;
chest X-ray and bone scan showed no other lesions.
The patient underwent en-bloc tumour excision with
distal pancreatectomy, splenectomy, partial
gastrectomy and left hemicolectomy. Histologically a
metastatic lesion was found consisting ofa moderately
differentiated clear cell carcinoma. Comparison of this
pathology specimen with the original renal tumour
revealed an almost identical tumour. The postopera-
tive course was uneventful and the patient was dis-
charged on the tenth postoperative day. At 6 months
follow-up, hewas well without evidence ofrecurrence on
abdominal or thoracic CT scan.
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Figure 1 Abdominal CT in 1992 depicting a tumorous lesion in the tail of the pancreas invading the transverse colon and the greater
curvature of the stomach.
DISCUSSION
Metastatic renal cell carcinoma, whether synchronous
or metachronous, has a poor prognosis, five-year
survival rates range from 0 to 19%3, and survival
beyond 10 years is rare4’5. In selected series, combined
resection of the primary renal tumour and of a
solitary lung metastasis has produced a 5-year sur-
vival rate of 25-35%
Late recurrence of a renal tumour after curative
resection is uncommon, but it can occur after disease-
free intervals of several years. Petersen found 23 re-
ported cases of recurrent renal carcinoma after 10 to
37 years3. Most of these recurrences were in the lung,
and recurrence in the pancreas, colon or stomach has
not been described. Prolonged survival can follow
surgical excision of the late metastasis.
Although our patient presented initially with a syn-
chronous pulmonary metastasis, he did well for 10
years after radical tumour surgery. Again, despite the
local extension of the pancreatic metastasis, radical
excision was both feasible and well tolerated by the
patient. Abnormal tumour-host interactions may be
responsible for the unusual sites and intervals ofrecur-
rence observed. Removal of a solitary late metastasis
can be followed by further disease-free survival of up
to 17 years7.
Operative treatment is seldom indicated for pancre-
atic metastases although there are some reports for
isolated metastasis of melanoma Seventeen cases of
renal carcinoma presenting with pancreatic
metastasis have been reported 2,9,10,11, and this can be an
occasional indication for pancreatectomy.
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Invited Commentary
Metastasis to the pancreas is distinctly uncommon,
being described at autopsy in only 3-5% of patients
with generalized malignancies 1’2. Usually the primary
tumour is bronchogenic carcinoma, breast carcinoma
or melanoma, but metastases have been reported from
a wide variety of primaries such as the thyroid, colon
and kidney3’4.
Renal cell carcinoma, in particular, can behave in
a variable and somewhat unpredictable manner.
Although most patients with this disease die within
a year, up to 20% may have periods of slow
tumour growth or stability lasting many years6,
during which time metachronous carcinoma or
metastasis to unusual sites may occur despite
radical resection of the initial tumour7. In a review
of 506 patients with renal cell carcinoma, Mc Nichols
et al. found that among the 158 patients who survived
more than 10 years, 11% had late recurrence in
the form ofmetastases8. As with the case ofDr. Barras,
25% of all renal cell carcinoma patients first
present with metastasis 9,10, usually to the lungs, lymph
nodes, liver and bone. The site of metastasis seems to
influence survival and response to treatment. In a
study of 181 cases, Maldazys et al. noted that patients
with metastasis limited to the lung parenchyma sur-
vived longer than those with metastasis to other single
or multiple organs.
Metastatic involvement ofthe pancreas is often part
ofwidespread nodal and visceral involvement 11, while
solitary metastasis to the pancreas is rare, with an
incidence of 1-3,/012 Metastasis to the ampulla of
Vater is even more uncommon; very few cases have
been reported so far, as shown by Tsao et al. in the
present report. Most of these patients presented with
symptoms of gastrointestinal bleeding and/or jaun-
dice, whereas half those with pancreatic metastasis
may be asymptomatic6. The patient ofDr. Barras who
presented with haematochezia secondary to colonic
erosion was unusual.
The five-year survival rate of patients with untrea-
ted metastatic renal cell carcinoma is poor, usually less
than 13%
13 With surgical removal of pulmonary
metastases, Tolia and Whitmore
12 noted a 35 % five-
year survival rate. Because of the small number of
cases, no clear conclusions can be drawn regarding
pancreatic metastasis from renal cell carcinoma.
However, a recent review ofthe world literature cover-
ing sixteen patients with resection of renal metastases
to the pancreas endorsed the value of operative treat-
ment14. In general, the factors associated with a fa-
vourable prognosis after resection of such
metastases include: 1) A long interval from the time of
resection of the primary tumour, 2) evidence of a
solitary lesion on radiographic examination, even if
multiple nodules are found at operation, 3) demon-
stration of extensive necrosis in the resected speci-
men5’14. The extent of pancreatectomy should be
dictated by the location of the lesion and the need for
an adequate margin of resection. If the disease is
limited to the pancreas (or ampulla) or even if it is
locally spreading but technically resectable (as in the
patient of Dr. Barras), a radical surgical strategy is
justified. It is not clearwhy Dr. Tsao and her colleagues
elected to perform a transduodenal excision of the
ampullary metastasis in their second patient rather
than a formal pancreatoduodenectomy which might
conceivably have prevented local recurrence.
As adjuvant irradiation and/or chemotherapy does
not seem to prolong the survival of patients with
pancreatic metastases, including renal secondaries3,
and because the outlook is generally dismal, it seems
that radical surgery should be offered to these rare
patients.
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